NORRISTOWN, Pa.–(BUSINESS WIRE)–Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™). The implantations were performed by the Principal Investigator, Jaroslaw Trebacz, MD, at the Specialty Hospital Jana Pawla II, Krakow, Poland. The study was approved by the […]
Other News
TransMedics Reports Second Quarter 2022 Financial Results
Accelerated Commercial Momentum to Achieve Net Revenue of $20.5 million 2022 Revenue Guidance Range Raised to $67 million to $75 million ANDOVER, Mass., Aug. 1, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 29, 2022 it granted stock options to purchase an aggregate of 88,200 shares of common stock to 11 new employees, whose employment commenced in July 2022, as a material inducement to […]
FUJIFILM Sonosite is now the Exclusive Ultrasound Sponsor of The Resuscitative TEE Workshop
Bothell, WA, Aug. 02, 2022 (GLOBE NEWSWIRE) — FUJIFILM Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – is now the exclusive ultrasound sponsor of The Resuscitative Transesophageal Echocardiography (TEE) Workshop, a prominent and globally active clinical education program presented by a multidisciplinary team of leaders in this emerging […]
Vektor Medical Bolsters Team to Accelerate Roll-Out of Computationally-Intelligent Technology
Arrhythmia innovator appoints strategic, AI and product executives as it ramps up commercial expansion SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map arrhythmias anywhere in the heart using only 12-lead ECG data, today announced the appointment of three key executives. The appointments, which come as […]
CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO®
Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol CORRECTION…by Soleo Health August 01, 2022 07:17 PM Eastern Daylight Time FRISCO, Texas–(BUSINESS WIRE)–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO® The updated release reads: SOLEO HEALTH […]
Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient save from a successful defibrillation early in the enrollment of the Investigational Device Exception (IDE) Study of its Jewel Patch Wearable […]
Ra Medical Systems Provides Update on its Annual Filings
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2022 and Amended Form […]
Non-tapered Catheter Success in Critical Limb Ischemia Pedal Artery Access
XO Cross Catheter Platform successfully used in peripheral vascular procedures utilizing pedal artery retrograde access to treat complex Critical Limb Ischemia (CLI) patients. PARK CITY, Utah, Aug. 1, 2022 /PRNewswire/ — Transit Scientific reports multiple successful peripheral vascular procedures with the XO Cross Catheter Platform utilizing pedal retrograde access. The non-tapered 2Fr […]
BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial
SUNNYVALE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the activation of Ottawa Heart Institute, the first Canadian clinical investigational site for the CardiAMP® Cell Therapy Heart Failure Trial. “The Ottawa Heart […]



